Oseltamivir phosphate is a prescription antiviral medication used to treat influenza A and B (the flu) and to prevent flu infection in people who have been exposed to the virus. Sold under the brand name Tamiflu, it works best when started within 48 hours of the first symptoms. It’s approved for treatment in patients as young as two weeks old and for prevention in anyone one year of age and older.
How It Treats the Flu
Oseltamivir phosphate is approved for treating acute, uncomplicated influenza in people who have been sick for no more than two days. The standard course is twice daily for five days. For adults and teens 13 and older, each dose is 75 mg. Children ages 1 to 12 receive doses based on body weight, ranging from 30 mg to 75 mg. Infants as young as two weeks old can be treated at a weight-based dose of 3 mg per kilogram.
Starting treatment early matters. Clinical benefit is greatest when the medication begins within 48 hours of symptom onset, and ideally within 36 hours. In hospitalized patients, early treatment with oseltamivir has been linked to better outcomes compared to later starts. That said, the CDC has issued guidance supporting treatment beyond the 48-hour window in certain situations, particularly for people at higher risk of complications.
In terms of how much faster you’ll feel better, clinical trials show a modest effect. On average, oseltamivir shortened symptom duration by about a third of a day compared to standard care. That number may sound small, but for people at high risk of serious complications, the benefit lies more in preventing the flu from getting worse than in shaving time off a sore throat.
How It Prevents Flu After Exposure
Beyond treatment, oseltamivir phosphate is also used as preventive therapy, called chemoprophylaxis. If you’ve had close contact with someone who has the flu, taking oseltamivir once daily (instead of twice daily) for at least 10 days can reduce your chances of getting sick. During a community outbreak, it can be taken once daily for longer stretches, up to six weeks in children.
Prevention use is not approved for infants under one year old. For adults and teens, the preventive dose is the same 75 mg capsule, just taken once a day instead of twice.
How It Works in the Body
The flu virus uses a protein on its surface called neuraminidase to break free from infected cells and spread to new ones. Oseltamivir blocks that protein. Without functioning neuraminidase, newly formed virus particles get stuck on the surface of the cell they came from. They clump together instead of spreading, which slows the infection and gives your immune system time to catch up.
This mechanism works against both influenza A and influenza B, which sets it apart from older antiviral drugs that only target influenza A. Current surveillance data from the CDC shows that resistance to oseltamivir remains extremely rare. Of 354 flu viruses tested in the U.S. during the 2024-2025 season, none showed clinically significant resistance.
Who Benefits Most
While anyone with the flu can take oseltamivir, it’s most strongly recommended for people at higher risk of flu complications. That includes adults 65 and older, children under 5 (especially those under 2), people with chronic conditions like asthma, diabetes, or heart disease, and anyone with a weakened immune system.
Pregnant women are a particularly important group. Pregnancy increases the risk of serious flu complications, including respiratory failure. Oral oseltamivir is the preferred antiviral during pregnancy because it has the most safety data behind it. It can be taken in any trimester, and health providers are advised not to wait for lab confirmation of the flu before starting treatment. Because pregnancy changes how the kidneys filter medication, some women may need a slightly higher dose to achieve effective drug levels, though standard dosing remains the default.
For postpartum women (up to two weeks after delivery, including after pregnancy loss), the same treatment and prevention recommendations apply. Oseltamivir can also be used as preventive therapy during pregnancy for women who were exposed to the flu and cannot receive or are unlikely to respond to the flu vaccine.
Common Side Effects
The most frequent side effects are nausea and vomiting. In adult treatment trials, about 10% of people experienced nausea without vomiting (compared to 6% on placebo), and about 9% experienced vomiting (compared to 3% on placebo). Children are somewhat more prone to stomach upset: 14% of children on oseltamivir vomited, compared to 8.5% on placebo. Only about 1% of trial participants stopped taking the drug because of these symptoms.
Taking oseltamivir with food can help reduce nausea.
Neuropsychiatric Effects in Children
Reports from Japan raised concern about unusual behavioral side effects in children, including delirium, hallucinations, confusion, and abnormal behavior. These reports were almost entirely from Japanese children and coincided with a period of intensive safety monitoring and high awareness of flu-related brain complications in that country. After reviewing the evidence, the FDA concluded that it could not establish a causal link between oseltamivir and these events. Influenza itself is known to cause neurological symptoms in children, which complicates the picture. In clinical trials, children taking oseltamivir experienced side effects similar to those in children not taking the drug.
Drug Interactions and Kidney Considerations
Oseltamivir has relatively few known drug interactions. The body clears it through the kidneys, so any medication that competes for the same kidney filtration pathway could theoretically raise oseltamivir levels in the blood. The most well-documented example is probenecid (a gout medication), which roughly doubles the blood concentration of oseltamivir’s active form by cutting its kidney clearance in half. If you have reduced kidney function, your provider will likely adjust the dose to prevent the drug from building up.